NCT07575347 Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) Status NOT_YET_RECRUITING Phase N/A
NCT07560956 Quality of Life in Adults With Untreated Fabry Disease in Sweden (QoLUF) Status NOT_YET_RECRUITING Phase N/A
NCT07506083 Natural History in Fabry Disease With IVS4+919G>A Mutations Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07495410 Anderson-Fabry Disease Fitness Improvement Training: A-FAD-FIT Status ENROLLING_BY_INVITATION Phase NA
NCT07485660 Care Pathway for Patients With Fabry's Disease (Fabry-PATH) Status NOT_YET_RECRUITING Phase N/A
NCT07351136 Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease Status NOT_YET_RECRUITING Phase N/A
NCT07336394 Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques Status RECRUITING Phase N/A
NCT07277361 Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment Status RECRUITING Phase N/A
NCT07235709 Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study Status RECRUITING Phase N/A
NCT07187440 A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease Status RECRUITING Phase N/A
NCT07109375 Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting Status NOT_YET_RECRUITING Phase N/A
NCT06941025 Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding Status RECRUITING Phase N/A
NCT06935578 RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED) Status RECRUITING Phase N/A
NCT06904261 A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants Status RECRUITING Phase PHASE3
NCT06880250 Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry Disease Status ENROLLING_BY_INVITATION Phase N/A
NCT06819514 The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06813443 Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation Status RECRUITING Phase N/A